Biblioteca Humberto Rosselli Quijano
Información del autor
Documentos disponibles escritos por este autor (4)
Refinar búsqueda
[artículo]
| Título : |
Effects of asenapine in bipolar i patients meeting proxy criteria for moderate-to-severe mixed major depressive episodes : a post hoc analysis |
| Tipo de documento: |
texto impreso |
| Autores: |
Berk, Michael, Autor ; John W. G. Tiller, Autor ; Jun Zhao, Autor |
| Fecha de publicación: |
2020 |
| Artículo en la página: |
pp. 728–734 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Antipsicoticos, Benzodiazepinas, Trastorno bipolar, Trastorno bipolar, Trastorno depresivo mayor, Compuestos heterocíclicos, Olanzapina. |
| Resumen: |
Depression is the predominant psychosocial and suicide burden in bipolar disorder, yet there is a paucity of evidence-based treatments for bipolar depression. |
| Link: |
./index.php?lvl=notice_display&id=21853 |
in The Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.6 (Junio) . - pp. 728–734
|
[artículo]
| Título : |
Efficacy and safety of asenapine in a placebo- and haloperidol controlled trial in patients with acute exacerbation of schizophrenia |
| Tipo de documento: |
texto impreso |
| Autores: |
John M. Kane, Autor ; Michael Cohen, Autor ; Jun Zhao, Autor |
| Fecha de publicación: |
2022 |
| Artículo en la página: |
pp. 106-115 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Asenapina, Eficacia, Haloperidol, Seguridad, Esquizofrenia |
| Resumen: |
Asenapine is approved by the Food and Drugs Administration in adults for acute treatment of schizophrenia or of manic or mixed episodes associated with bipolar I disorder with or without psychotic features. In a double-blind 6-week trial, 458 patients with acute schizophrenia were randomly assigned to fixed-dose treatment with asenapine at 5 mg twice daily (BID), asenapine at 10 mg BID, placebo, or haloperidol at 4 mg BID (to verify assay sensitivity). |
| Link: |
./index.php?lvl=notice_display&id=29455 |
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 2 (Abril) . - pp. 106-115
[artículo] Efficacy and safety of asenapine in a placebo- and haloperidol controlled trial in patients with acute exacerbation of schizophrenia [texto impreso] / John M. Kane, Autor ; Michael Cohen, Autor ; Jun Zhao, Autor . - 2022 . - pp. 106-115. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 2 (Abril) . - pp. 106-115
| Palabras clave: |
Asenapina, Eficacia, Haloperidol, Seguridad, Esquizofrenia |
| Resumen: |
Asenapine is approved by the Food and Drugs Administration in adults for acute treatment of schizophrenia or of manic or mixed episodes associated with bipolar I disorder with or without psychotic features. In a double-blind 6-week trial, 458 patients with acute schizophrenia were randomly assigned to fixed-dose treatment with asenapine at 5 mg twice daily (BID), asenapine at 10 mg BID, placebo, or haloperidol at 4 mg BID (to verify assay sensitivity). |
| Link: |
./index.php?lvl=notice_display&id=29455 |
|
[artículo]
| Título : |
Weight change and metabolic effects of asenapine in patients with schizophrenia and bipolar disorder |
| Tipo de documento: |
texto impreso |
| Autores: |
David E. Kemp, Autor ; Jun Zhao, Autor ; Pilar Cazorla, Autor |
| Fecha de publicación: |
2022 |
| Artículo en la página: |
pp. 238-245 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Antipsicóticos, Benzodiazepinas, Trastorno bipolar, Índice de masa corporal, Colesterol LDL, Ensayos clínicos controlados, Olanzapina, Esquizofrenia, Triglicéridos. |
| Resumen: |
To describe weight changes and metabolic effects of asenapine compared with placebo and olanzapine in adults.
Post hoc analyses were performed using data from 17 asenapine trials (13 schizophrenia and 4 bipolar mania trials) with placebo (5-10 mg twice daily; n = 1,748; 1-6 weeks) and/or olanzapine (5-20 mg, once daily; n = 3,430; 3-100 weeks). |
| Link: |
./index.php?lvl=notice_display&id=27809 |
in The Journal of Clinical Psychiatry > Año 2014 - Vol.75 - No.3 (Marzo) . - pp. 238-245
[artículo] Weight change and metabolic effects of asenapine in patients with schizophrenia and bipolar disorder [texto impreso] / David E. Kemp, Autor ; Jun Zhao, Autor ; Pilar Cazorla, Autor . - 2022 . - pp. 238-245. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in The Journal of Clinical Psychiatry > Año 2014 - Vol.75 - No.3 (Marzo) . - pp. 238-245
| Palabras clave: |
Antipsicóticos, Benzodiazepinas, Trastorno bipolar, Índice de masa corporal, Colesterol LDL, Ensayos clínicos controlados, Olanzapina, Esquizofrenia, Triglicéridos. |
| Resumen: |
To describe weight changes and metabolic effects of asenapine compared with placebo and olanzapine in adults.
Post hoc analyses were performed using data from 17 asenapine trials (13 schizophrenia and 4 bipolar mania trials) with placebo (5-10 mg twice daily; n = 1,748; 1-6 weeks) and/or olanzapine (5-20 mg, once daily; n = 3,430; 3-100 weeks). |
| Link: |
./index.php?lvl=notice_display&id=27809 |
|
